ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +5 | 282.32M | $20.34B | +9 | −3 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | — | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | — |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | — | — |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | — |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | — | 38.28M | $6.63B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passiv) | 10.24M | — | $1.77B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 10.24M | — | $1.77B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 9.44M | — | $1.64B | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Capital World Investors ✦ | 6.78M | — | $1.18B | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (passiv) | 5.01M | — | $868.01M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 4.79M | — | $831.08M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 4.79M | — | $831.08M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 835.68K | — | $144.87M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 835.68K | — | $144.87M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 835.68K | — | $144.87M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 397.93K | — | $68.98M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 261.28K | — | $45.30M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 261.28K | — | $45.30M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 138.82K | — | $24.07M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 110.42K | — | $19.14M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 97.48K | — | $16.90M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 97.48K | — | $16.90M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 97.48K | — | $16.90M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Bridgewater Associates ✦ | 82.72K | — | $14.34M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 70.03K | — | $12.14M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 70.03K | — | $12.14M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | GAMCO Investors ✦ | 14.63K | — | $2.54M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fisher Asset Management ✦ | 4.01K | — | $695,978 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 2.54K | — | $441,201 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Dodge & Cox ✦ | 1.70K | — | $294,712 | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1,596 Inhaber, 404.54M Anteile, $46.32B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.